{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T16:14:05Z","timestamp":1785600845937,"version":"3.56.0"},"reference-count":103,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T00:00:00Z","timestamp":1693353600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009812","name":"Princess Margaret Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009812","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000521","name":"Canadian Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000521","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012118","name":"Ontario Institute for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012118","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012772","name":"Canadian Imperial Bank of Commerce","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012772","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003579","name":"University of Toronto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003579","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100025522","name":"FDC Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100025522","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004376","name":"Terry Fox Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004376","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017559","name":"Garron Family Cancer Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017559","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100027042","name":"Sharks Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100027042","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001545","name":"Children's Tumor Foundation","doi-asserted-by":"publisher","award":["2018-10-002"],"award-info":[{"award-number":["2018-10-002"]}],"id":[{"id":"10.13039\/100001545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Human Genetics"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.ajhg.2023.08.014","type":"journal-article","created":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T10:27:56Z","timestamp":1696501676000},"page":"1616-1627","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Current and new frontiers in hereditary cancer surveillance: Opportunities for liquid biopsy"],"prefix":"10.1016","volume":"110","author":[{"given":"Kirsten M.","family":"Farncombe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maia L.","family":"Norman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie E.","family":"Oldfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia A.","family":"Sobotka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Basik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Bombard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Carile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesa","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D.","family":"Foulkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Malkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aly","family":"Karsan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Parkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynette S.","family":"Penney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Pollett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasmintan A.","family":"Schrader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor J.","family":"Pugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond H.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Aguilar-Mahecha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melyssa","family":"Aronson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Basik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy N.","family":"Baxter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phil","family":"Bedard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hal","family":"Berman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus Q.","family":"Bernardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Bombard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Carile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarissa F.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tulin","family":"Cil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blaise","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesa","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irfan","family":"Dhalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Elser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle EV.","family":"Ene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten M.","family":"Farncombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D.","family":"Foulkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Genge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Gryfe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle R.","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aly","family":"Karsan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Kastner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pardeep","family":"Kaurah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond H.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josiane","family":"Lafleur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Lerner-Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Lheureux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelley M.","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanna","family":"McCuaig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Mckee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Mittmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maia L.","family":"Norman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie E.","family":"Oldfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema","family":"Panchal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynette S.","family":"Penney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Piccinin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Pollett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor J.","family":"Pugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean","family":"Regier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoulikha","family":"Rezoug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krista","family":"Rideout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasmintan A.","family":"Schrader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara","family":"Semotiuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lillian","family":"Siu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia A.","family":"Sobotka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Thain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelley","family":"Westergard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacy","family":"Whittle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celeste","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajhg.2023.08.014_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/npjgenmed.2015.6","article-title":"Precision medicine in heritable cancer: when somatic tumour testing and germline mutations meet","volume":"1","author":"Ngeow","year":"2016","journal-title":"NPJ Genom. Med."},{"key":"10.1016\/j.ajhg.2023.08.014_bib2","article-title":"A game-changer for hereditary cancer patients","volume":"189","author":"Cooper-Jones","year":"2017","journal-title":"CMAJ (Can. Med. Assoc. J.)"},{"key":"10.1016\/j.ajhg.2023.08.014_bib3","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1056\/NEJMra1503523","article-title":"The role of risk-reducing surgery in hereditary breast and ovarian cancer","volume":"374","author":"Hartmann","year":"2016","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ajhg.2023.08.014_bib4","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.6004\/jnccn.2019.0044","article-title":"NCCN guidelines insights: genetic\/familial high-risk assessment: colorectal, version 2.2019","volume":"17","author":"Gupta","year":"2019","journal-title":"J.\u00a0Natl. Compr. Canc. Netw."},{"key":"10.1016\/j.ajhg.2023.08.014_bib5","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1177\/1947601911413466","article-title":"Li-Fraumeni syndrome","volume":"2","author":"Malkin","year":"2011","journal-title":"Genes Cancer"},{"key":"10.1016\/j.ajhg.2023.08.014_bib6","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/humu.22559","article-title":"Germline TP53 mutations and the changing landscape of Li-Fraumeni syndrome","volume":"35","author":"Kamihara","year":"2014","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ajhg.2023.08.014_bib7","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1200\/JCO.2014.59.5728","article-title":"Revisiting Li-Fraumeni syndrome from TP53 mutation carriers","volume":"33","author":"Bougeard","year":"2015","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ajhg.2023.08.014_bib8","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1200\/JCO.2015.65.3576","article-title":"Distinctive cancer associations in patients with Neurofibromatosis type 1","volume":"34","author":"Uusitalo","year":"2016","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ajhg.2023.08.014_bib9","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1158\/1078-0432.CCR-17-0589","article-title":"Cancer and central nervous system tumor surveillance in pediatric Neurofibromatosis 1","volume":"23","author":"Evans","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ajhg.2023.08.014_bib10","article-title":"Genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 1.2023, NCCN clinical practice guidelines in oncology","author":"Daly","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.ajhg.2023.08.014_bib11","article-title":"NCCN guidelines\u00ae insights: genetic\/familial high-risk assessment: colorectal, version 1.2022","author":"Gupta","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.ajhg.2023.08.014_bib12","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1158\/1078-0432.CCR-17-0408","article-title":"Cancer screening recommendations for individuals with Li-Fraumeni syndrome","volume":"23","author":"Kratz","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ajhg.2023.08.014_bib13","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1038\/s41431-020-0638-4","article-title":"Guidelines for the Li-Fraumeni and heritable TP53-related cancer syndromes","volume":"28","author":"Frebourg","year":"2020","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.ajhg.2023.08.014_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmg.2021.104350","article-title":"Overview of hereditary breast and ovarian cancer (HBOC) guidelines across Europe","volume":"64","author":"Marmolejo","year":"2021","journal-title":"Eur. J. Med. Genet."},{"key":"10.1016\/j.ajhg.2023.08.014_bib15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.annonc.2022.10.004","article-title":"Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline","volume":"34","author":"Sessa","year":"2023","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ajhg.2023.08.014_bib16","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1136\/jmedgenet-2020-106876","article-title":"UKCGG Consensus Group guidelines for the management of patients\u00a0with constitutional TP53 pathogenic variants","volume":"58","author":"Hanson","year":"2020","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.ajhg.2023.08.014_bib17","doi-asserted-by":"crossref","first-page":"5265","DOI":"10.1200\/JCO.2009.27.2294","article-title":"BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study","volume":"28","author":"Rijnsburger","year":"2010","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ajhg.2023.08.014_bib18","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/bjc.2012.204","article-title":"Long-term results of screening with magnetic resonance imaging in women with BRCA mutations","volume":"107","author":"Passaperuma","year":"2012","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ajhg.2023.08.014_bib19","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1200\/JCO.2014.56.8626","article-title":"Triple-modality screening trial for familial breast cancer underlines the importance of magnetic resonance imaging and questions the role of mammography and ultrasound regardless of patient mutation status, age, and breast density","volume":"33","author":"Riedl","year":"2015","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ajhg.2023.08.014_bib20","first-page":"1122","article-title":"NCCN guidelines\u00ae insights: genetic\/familial high-risk assessment: colorectal, version 1.2021","volume":"19","author":"Weiss","year":"2021","journal-title":"J.\u00a0Natl. Compr. Canc. Netw."},{"key":"10.1016\/j.ajhg.2023.08.014_bib21","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1470-2045(11)70119-X","article-title":"Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study","volume":"12","author":"Villani","year":"2011","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ajhg.2023.08.014_bib22","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S1470-2045(16)30249-2","article-title":"Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study","volume":"17","author":"Villani","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ajhg.2023.08.014_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.socscimed.2022.114905","article-title":"Embodied risk for families with Li-Fraumeni syndrome: like electricity through my body","volume":"301","author":"Werner-Lin","year":"2022","journal-title":"Soc. Sci. Med."},{"key":"10.1016\/j.ajhg.2023.08.014_bib24","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2019-0660","article-title":"Health supervision for children with Neurofibromatosis type 1","volume":"143","author":"Miller","year":"2019","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajhg.2023.08.014_bib25","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/gim.2018.28","article-title":"Care of adults with Neurofibromatosis type 1: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)","volume":"20","author":"Stewart","year":"2018","journal-title":"Genet. Med."},{"key":"10.1016\/j.ajhg.2023.08.014_bib26","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1177\/1557988315610806","article-title":"Within-gender differences in medical decision making among male carriers of the BRCA genetic mutation for hereditary breast cancer","volume":"11","author":"Hesse-Biber","year":"2017","journal-title":"Am. J. Men's Health"},{"key":"10.1016\/j.ajhg.2023.08.014_bib27","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.3390\/curroncol29040203","article-title":"Psychological determinants of men's adherence to cascade screening for BRCA1\/2","volume":"29","author":"Ongaro","year":"2022","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.ajhg.2023.08.014_bib28","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nature12981","article-title":"Realizing the promise of cancer predisposition genes","volume":"505","author":"Rahman","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ajhg.2023.08.014_bib29","article-title":"Poly (ADP-ribose) polymerase inhibitors in the management of ovarian cancer","volume":"14","author":"Markman","year":"2018","journal-title":"Womens Health (Lond)"},{"key":"10.1016\/j.ajhg.2023.08.014_bib30","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1056\/NEJMoa1912735","article-title":"Selumetinib in children with inoperable plexiform neurofibromas","volume":"382","author":"Gross","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ajhg.2023.08.014_bib31","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40364-021-00281-0","article-title":"MEK inhibitors - novel targeted therapies of neurofibromatosis associated benign and malignant lesions","volume":"9","author":"Harder","year":"2021","journal-title":"Biomark. Res."},{"key":"10.1016\/j.ajhg.2023.08.014_bib32","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","article-title":"PD-1 blockade in tumors with mismatch-repair deficiency","volume":"372","author":"Le","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ajhg.2023.08.014_bib33","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1200\/JCO.20.00299","article-title":"Management of hereditary breast cancer: American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Guideline","volume":"38","author":"Tung","year":"2020","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ajhg.2023.08.014_bib34","first-page":"217","article-title":"Recent progress in Lynch syndrome and other familial colorectal cancer syndromes","volume":"68","author":"Boland","year":"2018","journal-title":"CA. Cancer J. Clin."},{"key":"10.1016\/j.ajhg.2023.08.014_bib35","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12943-022-01588-8","article-title":"Potential clinical utility of liquid biopsies in ovarian cancer","volume":"21","author":"Zhu","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ajhg.2023.08.014_bib36","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.3748\/wjg.v27.i17.1943","article-title":"BRCA mutated pancreatic cancer: a change is coming","volume":"27","author":"Rosen","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ajhg.2023.08.014_bib37","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1177\/1758834017714993","article-title":"BRCA mutation in ovarian cancer: testing, implications and treatment considerations","volume":"9","author":"Neff","year":"2017","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.ajhg.2023.08.014_bib38","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12905-014-0150-5","article-title":"Risk-reducing salpingo-oophorectomy: a meta-analysis on impact on ovarian cancer risk and all cause mortality in BRCA 1 and BRCA 2 mutation carriers","volume":"14","author":"Marchetti","year":"2014","journal-title":"BMC Wom. Health"},{"key":"10.1016\/j.ajhg.2023.08.014_bib39","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1897-4287-9-8","article-title":"Lynch syndrome: barriers to and facilitators of screening and disease management","volume":"9","author":"Watkins","year":"2011","journal-title":"Hered. Cancer Clin. Pract."},{"key":"10.1016\/j.ajhg.2023.08.014_bib40","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1038\/gim.2017.8","article-title":"The psychosocial effects of the Li-Fraumeni Education and Early Detection (LEAD) program on individuals with Li-Fraumeni syndrome","volume":"19","author":"Ross","year":"2017","journal-title":"Genet. Med."},{"key":"10.1016\/j.ajhg.2023.08.014_bib41","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s10689-010-9368-z","article-title":"Regular surveillance for Li-Fraumeni syndrome: advice, adherence and perceived benefits","volume":"9","author":"Lammens","year":"2010","journal-title":"Fam. Cancer"},{"key":"10.1016\/j.ajhg.2023.08.014_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejon.2022.102117","article-title":"Experiences of living with Lynch syndrome: a reflexive thematic analysis","volume":"58","author":"Warner","year":"2022","journal-title":"Eur. J. Oncol. Nurs."},{"key":"10.1016\/j.ajhg.2023.08.014_bib43","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.pec.2020.07.017","article-title":"Uncertainty management for individuals with Lynch syndrome: identifying and responding to healthcare barriers","volume":"104","author":"Campbell-Salome","year":"2021","journal-title":"Patient Educ. Couns."},{"key":"10.1016\/j.ajhg.2023.08.014_bib44","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3390\/jpm4010020","article-title":"Barriers and motivators for referral of patients with suspected Lynch syndrome to cancer genetic services: a qualitative study","volume":"4","author":"Tan","year":"2014","journal-title":"J.\u00a0Pers. Med."},{"key":"10.1016\/j.ajhg.2023.08.014_bib45","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13053-015-0031-4","article-title":"Decisions about prophylactic gynecologic surgery: a qualitative study of the experience of female Lynch syndrome mutation carriers","volume":"13","author":"Etchegary","year":"2015","journal-title":"Hered. Cancer Clin. Pract."},{"key":"10.1016\/j.ajhg.2023.08.014_bib46","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/gim.2014.183","article-title":"Challenges in managing genetic cancer risk: a long-term qualitative study of unaffected women carrying BRCA1\/BRCA2 mutations","volume":"17","author":"Caiata-Zufferey","year":"2015","journal-title":"Genet. Med."},{"key":"10.1016\/j.ajhg.2023.08.014_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12071874","article-title":"Cost-effectiveness of early detection and prevention strategies for endometrial cancer - a systematic review","volume":"12","author":"Sroczynski","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.ajhg.2023.08.014_bib48","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.23616","article-title":"Cost-effectiveness analysis of genotype-specific surveillance and preventive strategies for gynecologic cancers among women with Lynch syndrome","volume":"4","author":"Wright","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.ajhg.2023.08.014_bib49","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s10549-010-1043-4","article-title":"Comparative effectiveness of screening and prevention strategies among BRCA1\/2-affected mutation carriers","volume":"125","author":"Grann","year":"2011","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.ajhg.2023.08.014_bib50","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.29021","article-title":"Tumor surveillance for children and adolescents with cancer predisposition syndromes: The psychosocial impact reported by adolescents and caregivers","volume":"68","author":"van Engelen","year":"2021","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.ajhg.2023.08.014_bib51","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.lungcan.2016.08.002","article-title":"Scan-associated distress in lung cancer: quantifying the impact of \"scanxiety\"","volume":"100","author":"Bauml","year":"2016","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ajhg.2023.08.014_bib52","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.critrevonc.2012.01.004","article-title":"Surveillance for hereditary cancer: does the benefit outweigh the psychological burden?--A systematic review","volume":"83","author":"Gopie","year":"2012","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.ajhg.2023.08.014_bib53","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1007\/s10897-015-9929-2","article-title":"Genetic testing and post-testing decision making among BRCA-positive mutation women: a psychosocial approach","volume":"25","author":"Hesse-Biber","year":"2016","journal-title":"J.\u00a0Genet. Couns."},{"key":"10.1016\/j.ajhg.2023.08.014_bib54","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/GIM.0b013e3181f48d1c","article-title":"Time to prophylactic surgery in BRCA1\/2 carriers depends on psychological and other characteristics","volume":"12","author":"Julian-Reynier","year":"2010","journal-title":"Genet. Med."},{"key":"10.1016\/j.ajhg.2023.08.014_bib55","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1586\/14737159.2015.1110021","article-title":"Testing for oncogenic molecular aberrations in cell-free DNA-based liquid biopsies in the clinic: are we there yet?","volume":"15","author":"Polivka","year":"2015","journal-title":"Expert Rev. Mol. Diagn."},{"key":"10.1016\/j.ajhg.2023.08.014_bib56","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1186\/s12884-021-04044-5","article-title":"Cell-free fetal DNA testing and its correlation with prenatal indications","volume":"21","author":"Wang","year":"2021","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.ajhg.2023.08.014_bib57","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.639233","article-title":"Cell-free DNA: hope and potential application in cancer","volume":"9","author":"Yan","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ajhg.2023.08.014_bib58","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1158\/1078-0432.CCR-20-4805","article-title":"Genomic analysis of circulating tumor DNA in 3,334 patients with advanced prostate cancer identifies targetable BRCA alterations and AR resistance mechanisms","volume":"27","author":"Tukachinsky","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ajhg.2023.08.014_bib59","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1038\/s41467-021-24109-5","article-title":"Enhanced specificity of clinical high-sensitivity tumor mutation profiling in cell-free DNA via paired normal sequencing using MSK-ACCESS","volume":"12","author":"Rose Brannon","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ajhg.2023.08.014_bib60","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41571-019-0187-3","article-title":"Liquid biopsy and minimal residual disease - latest advances and implications for cure","volume":"16","author":"Pantel","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ajhg.2023.08.014_bib61","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s43018-020-0043-5","article-title":"Circulating tumor DNA and liquid biopsy in oncology","volume":"1","author":"Cescon","year":"2020","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.ajhg.2023.08.014_bib62","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/s41467-017-00965-y","article-title":"Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors","volume":"8","author":"Adalsteinsson","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ajhg.2023.08.014_bib63","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12061481","article-title":"Shallow whole-genome sequencing from plasma identifies FGFR1 amplified breast cancers and predicts overall survival","volume":"12","author":"Bourrier","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.ajhg.2023.08.014_bib64","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/s41591-020-0915-3","article-title":"Genome-wide cell-free DNA mutational integration enables ultra-sensitive cancer monitoring","volume":"26","author":"Zviran","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.ajhg.2023.08.014_bib65","article-title":"Machine learning guided signal enrichment for ultrasensitive plasma tumor burden monitoring","author":"Widman","year":"2022","journal-title":"bioRxiv"},{"key":"10.1016\/j.ajhg.2023.08.014_bib66","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41586-022-04975-9","article-title":"Deep whole-genome ctDNA chronology of treatment-resistant prostate cancer","volume":"608","author":"Herberts","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ajhg.2023.08.014_bib67","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat4921","article-title":"Enhanced detection of circulating tumor DNA by fragment size analysis","volume":"10","author":"Mouliere","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ajhg.2023.08.014_bib68","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cell.2015.11.050","article-title":"Cell-free DNA comprises an in\u00a0vivo nucleosome footprint that informs its tissues-of-origin","volume":"164","author":"Snyder","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.ajhg.2023.08.014_bib69","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1814616115","article-title":"Preferred end coordinates and somatic variants as signatures of circulating tumor DNA associated with hepatocellular carcinoma","volume":"115","author":"Jiang","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ajhg.2023.08.014_bib70","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.1038\/s41467-019-12714-4","article-title":"Inference of transcription factor binding from cell-free DNA enables tumor subtype prediction and early detection","volume":"10","author":"Ulz","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ajhg.2023.08.014_bib71","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1158\/2159-8290.CD-19-0622","article-title":"Plasma DNA end-motif profiling as a fragmentomic marker in cancer, pregnancy, and transplantation","volume":"10","author":"Jiang","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ajhg.2023.08.014_bib72","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/s41586-019-1272-6","article-title":"Genome-wide cell-free DNA fragmentation in patients with cancer","volume":"570","author":"Cristiano","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ajhg.2023.08.014_bib73","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.annonc.2020.02.011","article-title":"Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA","volume":"31","author":"Liu","year":"2020","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ajhg.2023.08.014_bib74","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13073-020-00750-5","article-title":"cfNOMe - a single assay for comprehensive epigenetic analyses of cell-free DNA","volume":"12","author":"Erger","year":"2020","journal-title":"Genome Med."},{"key":"10.1016\/j.ajhg.2023.08.014_bib75","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2209852119","article-title":"Epigenetic analysis of cell-free DNA by fragmentomic profiling","volume":"119","author":"Zhou","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ajhg.2023.08.014_bib76","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1038\/s41596-019-0202-2","article-title":"Preparation of cfMeDIP-seq libraries for methylome profiling of plasma cell-free DNA","volume":"14","author":"Shen","year":"2019","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ajhg.2023.08.014_bib77","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1038\/s41467-020-17316-z","article-title":"Non-invasive early detection of cancer four years before conventional diagnosis using a blood test","volume":"11","author":"Chen","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ajhg.2023.08.014_bib78","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/s41416-021-01594-5","article-title":"Cell-free DNA technologies for the analysis of brain cancer","volume":"126","author":"Mair","year":"2022","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ajhg.2023.08.014_bib79","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202012881","article-title":"Fragmentation patterns and personalized sequencing of cell-free DNA in urine and plasma of glioma patients","volume":"13","author":"Mouliere","year":"2021","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ajhg.2023.08.014_bib80","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/neuonc\/nop041","article-title":"Serum DNA can define tumor-specific genetic and epigenetic markers in gliomas of various grades","volume":"12","author":"Lavon","year":"2010","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.ajhg.2023.08.014_bib81","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1093\/neuonc\/noab023","article-title":"A serum-based DNA methylation assay provides accurate detection of glioma","volume":"23","author":"Sabedot","year":"2021","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.ajhg.2023.08.014_bib82","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1038\/s41591-020-0932-2","article-title":"Detection and discrimination of intracranial tumors using plasma cell-free DNA methylomes","volume":"26","author":"Nassiri","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.ajhg.2023.08.014_bib83","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/gm434","article-title":"Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing","volume":"5","author":"Heitzer","year":"2013","journal-title":"Genome Med."},{"key":"10.1016\/j.ajhg.2023.08.014_bib84","article-title":"The prognostic value of plasma cell-free DNA concentration in the prostate cancer: a systematic review and meta-analysis","volume":"11","author":"Liu","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ajhg.2023.08.014_bib85","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-89592-8","article-title":"Sensitivity, specificity, and accuracy of a liquid biopsy approach utilizing molecular amplification pools","volume":"11","author":"Garcia","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ajhg.2023.08.014_bib86","article-title":"The role of the liquid biopsy in decision-making for patients with non-small cell lung cancer","volume":"9","author":"Akhoundova","year":"2020","journal-title":"J.\u00a0Clin. Med."},{"key":"10.1016\/j.ajhg.2023.08.014_bib87","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12967-023-03960-8","article-title":"Liquid biopsies: the future of cancer early detection","volume":"21","author":"Connal","year":"2023","journal-title":"J.\u00a0Transl. Med."},{"key":"10.1016\/j.ajhg.2023.08.014_bib88","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.lungcan.2023.01.014","article-title":"Liquid biopsy-based decision support algorithms for diagnosis and subtyping of lung cancer","volume":"178","author":"Visser","year":"2023","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ajhg.2023.08.014_bib89","article-title":"Integrated analysis of cell-free DNA for the early detection of cancer in people with Li-Fraumeni Syndrome","author":"Wong","year":"2022","journal-title":"medRxiv"},{"key":"10.1016\/j.ajhg.2023.08.014_bib90","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23084284","article-title":"Liquid biopsy as a source of nucleic acid biomarkers in the diagnosis and management of Lynch syndrome","volume":"23","author":"Bugly\u00f3","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ajhg.2023.08.014_bib91","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003734","article-title":"Cell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: a cross-sectional study","volume":"18","author":"Szymanski","year":"2021","journal-title":"PLoS Med."},{"key":"10.1016\/j.ajhg.2023.08.014_bib92","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1158\/2159-8290.CD-22-0786","article-title":"Genomic patterns of malignant peripheral nerve sheath tumor (MPNST) evolution correlate with clinical outcome and are detectable in cell-free DNA","volume":"13","author":"Cortes-Ciriano","year":"2023","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ajhg.2023.08.014_bib93","doi-asserted-by":"crossref","first-page":"48832","DOI":"10.18632\/oncotarget.9453","article-title":"Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer","volume":"7","author":"Cheng","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ajhg.2023.08.014_bib94","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12943-017-0644-5","article-title":"Liquid biopsy: a step forward towards precision medicine in urologic malignancies","volume":"16","author":"Di Meo","year":"2017","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ajhg.2023.08.014_bib95","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/jnci\/djy156","article-title":"A prospective study of circulating tumor DNA to guide matched targeted therapy in lung cancers","volume":"111","author":"Sabari","year":"2019","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.ajhg.2023.08.014_bib96","doi-asserted-by":"crossref","DOI":"10.1177\/17588359221112696","article-title":"The economic value of liquid biopsy for genomic profiling in advanced non-small cell lung cancer","volume":"14","author":"Ezeife","year":"2022","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.ajhg.2023.08.014_bib97","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1007\/s00432-022-04034-w","article-title":"Clinical benefit and cost-effectiveness analysis of liquid biopsy application in patients with advanced non-small cell lung cancer (NSCLC): a modelling approach","volume":"149","author":"Englmeier","year":"2023","journal-title":"J.\u00a0Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.ajhg.2023.08.014_bib98","first-page":"1","article-title":"Cell-free circulating tumour DNA blood testing to detect EGFR T790M mutation in people with advanced non-small cell lung cancer: a health technology assessment","volume":"20","year":"2020","journal-title":"Ont. Health Technol. Assess. Ser."},{"key":"10.1016\/j.ajhg.2023.08.014_bib99","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14122951","article-title":"The early detection of breast cancer using liquid biopsies: model estimates of the benefits, harms, and costs","volume":"14","author":"van der Poort","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.ajhg.2023.08.014_bib100","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2147\/CEOR.S220726","article-title":"Analysis of the cost-effectiveness of liquid biopsy to determine treatment change in patients with Her2-positive advanced breast cancer in Colombia","volume":"12","author":"S\u00e1nchez-Calder\u00f3n","year":"2020","journal-title":"Clinicoecon. Outcomes Res."},{"key":"10.1016\/j.ajhg.2023.08.014_bib101","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.euros.2021.03.002","article-title":"Health economic evidence for liquid- and tissue-based molecular tests that inform decisions on prostate biopsies and treatment of localised prostate cancer: a systematic review","volume":"27","author":"Degeling","year":"2021","journal-title":"Eur. Urol. Open Sci."},{"key":"10.1016\/j.ajhg.2023.08.014_bib102","doi-asserted-by":"crossref","first-page":"e393","DOI":"10.1093\/oncolo\/oyac039","article-title":"\"Game changer\": health professionals' views on the clinical utility of circulating tumor DNA testing in hereditary cancer syndrome management","volume":"27","author":"Shickh","year":"2022","journal-title":"Oncol."},{"key":"10.1016\/j.ajhg.2023.08.014_bib103","article-title":"\u201cI just wanted more\u201d: Hereditary cancer syndromes patients\u2019 perspectives on the utility of circulating tumour DNA testing for cancer screening","author":"Bombard","year":"2023","journal-title":"Research Square"}],"container-title":["The American Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002929723002902?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002929723002902?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T20:57:32Z","timestamp":1783025852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002929723002902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":103,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S0002929723002902"],"URL":"https:\/\/doi.org\/10.1016\/j.ajhg.2023.08.014","relation":{},"ISSN":["0002-9297"],"issn-type":[{"value":"0002-9297","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current and new frontiers in hereditary cancer surveillance: Opportunities for liquid biopsy","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Human Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajhg.2023.08.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors.","name":"copyright","label":"Copyright"}]}}